Home / Companies / Lexicon Pharmaceuticals, Inc. / 2 Jun 2025
Lexicon Pharmaceuticals, Inc.: meeting of 2 Jun 2025
Votes reported on Form N-PX, item by item
143 Form N-PX filers reported votes at the Lexicon Pharmaceuticals, Inc. meeting of 2 Jun 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 82.0% of reported votes for; 12 filers withheld from or voted against at least one nominee.
174 vote records from 46 filers. 0 of the 45 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
201 vote records from 143 filers. 13 of the 132 filers that marked the item either way voted against management. 11 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
87 vote records from 46 filers. 0 of the 45 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
87 vote records from 46 filers. 0 of the 45 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
174 vote records from 46 filers. 1 of the 45 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | Split or no vote | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | Against * | No report |
| State Street and SPDR | For | For | For |
| Invesco | Split or no vote | Against * | For |
| Equitable | Split or no vote | For | For |
| Charles Schwab | For | For | For |
| ProShares and ProFunds | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Split or no vote | Against * | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | For | For | For |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | For | For |
| T. Rowe Price | For | For | For |
| Lincoln Financial | For | For | For |
| Voya | For | For | For |
| Nationwide | Split or no vote | For | For |
| Victory Capital | For | For | For |
| Guggenheim and Rydex | For | For | For |
| Columbia Threadneedle | Split or no vote | For | For |
| BNY Mellon | No report | For | No report |
| Principal | No report | For | No report |
| Pacific Life funds | Split or no vote | For | For |
| Global X | For | For | For |
| AllianceBernstein | No report | For | No report |
| DWS | For | For | For |
| Neuberger Berman | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Lexicon Pharmaceuticals, Inc. meeting?
143 Form N-PX filers reported votes at the meeting of 2 Jun 2025. On say-on-pay, 13 of 132 voted against management (9.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Lexicon Pharmaceuticals, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Lexicon Pharmaceuticals, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Lexicon Pharmaceuticals, Inc. with a meeting date within three days of 2 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.